The research team, led by Constance Lehman, MD, PhD, director of breast imaging at Mass General, published its findings in a paper online in the journal Radiology.
Researchers reviewed patients that had biopsy-proven high-risk breast lesions with at least two years of imaging follow-up to derive a machine learning model that can help identify lesions at low-risk for becoming cancerous. The model uses age and histologic results, as well as text features from the biopsy pathologic report to determine at-risk lesions.
The model identified 97 percent of lesions that were malignant and reduced unnecessary surgery by 30 percent.
“This study provides proof of concept that a machine learning model can be applied to predict the risk of upgrade of HRLs to cancer,” the authors wrote. “Use of this model … could help guide clinical decision making with regard to surveillance versus surgical excision of HRLs.”
More articles on artificial intelligence:
70% of hospital executives attribute growth to keeping up with technology trends
Medtronic, Mercy enter data sharing partnership to create more effective medical devices
NIH to collaborate with 11 drugmakers on cancer immunotherapy research
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.